| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/26/2002 | US6350446 Polypeptides with amino acid sequences for kidney failure |
| 02/26/2002 | US6350443 Method of treatment for feline leukemia virus infections |
| 02/26/2002 | CA2083177C Alveolar surfactant proteins |
| 02/26/2002 | CA2078875C High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
| 02/26/2002 | CA1341343C Immunoassay and biological constructs for use therein |
| 02/21/2002 | WO2002014860A1 Functional protein arrays |
| 02/21/2002 | WO2002014549A1 Method for combinatorial protein synthesis based on ribosomal frameshifting |
| 02/21/2002 | WO2002014525A2 Expression vector using for animal cell |
| 02/21/2002 | WO2002014518A1 Method of modifying microorganism-origin transglutaminase |
| 02/21/2002 | WO2002014511A2 Regulation of human p2y1-like g protein-coupled receptor |
| 02/21/2002 | WO2002014504A1 Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same |
| 02/21/2002 | WO2002014500A2 Human genes and gene expression products |
| 02/21/2002 | WO2002014499A2 Claudin polypeptides |
| 02/21/2002 | WO2002014489A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 02/21/2002 | WO2002014488A1 Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same |
| 02/21/2002 | WO2002014471A2 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
| 02/21/2002 | WO2002014468A2 Phage-dependent superproduction of biologically active protein and peptides |
| 02/21/2002 | WO2002014369A2 Human kininogen d5 domain polypeptides and their use |
| 02/21/2002 | WO2002014348A2 Glycoproteins and methods of use thereof |
| 02/21/2002 | WO2002013763A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 02/21/2002 | WO2002013633A1 Oil seed processing |
| 02/21/2002 | WO2002013606A2 Improved insecticidal bacteria, and methods for making and using them |
| 02/21/2002 | WO2001081608A3 Viral vectors for use in monitoring hiv drug resistance |
| 02/21/2002 | WO2001077149A3 Regulation of human cyslt2-like gpcr protein |
| 02/21/2002 | WO2001070807A3 G-protein associated molecules |
| 02/21/2002 | WO2001060856A3 Vmglom gene and its mutations causing disorders with a vascular component |
| 02/21/2002 | WO2001058276A3 Use of acid-stable proteases in animal feed |
| 02/21/2002 | WO2001058275A3 Use of acid-stable subtilisin proteases in animal feed |
| 02/21/2002 | WO2001055391A3 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 02/21/2002 | WO2001044282A3 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 02/21/2002 | WO2001032871A3 Follistatin-related protein zfsta4 |
| 02/21/2002 | WO2001031005A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/21/2002 | WO2000075662A9 Cell-signaling assays |
| 02/21/2002 | US20020022718 Genes identified as required for proliferation of E. coli |
| 02/21/2002 | US20020022717 Using monoclonal antibodies |
| 02/21/2002 | US20020022595 Treating inflammation resulting from a response of the non-specific defense system in a mammal by administering an antiinflammatory agent and the uncontaminated Mac-1 alpha subunit |
| 02/21/2002 | US20020022268 Culturing primate progenitor tissues; obtain tissues, harvest nutrients from culture, monitor tissue propagation |
| 02/21/2002 | US20020022251 Proteinaceous antimycotic complex derived from saccharomyces cerevisiae and its application |
| 02/21/2002 | US20020022238 Genetically engineered microorganism for use as tools in the generation of heterologous binding proteins |
| 02/21/2002 | US20020022035 Genetic engineering; deactivating toxin |
| 02/21/2002 | US20020022033 Diagnosis of Aids |
| 02/21/2002 | US20020022030 Product and process for regulation of T cell responses |
| 02/21/2002 | US20020022029 Human RRP sequences and methods of use |
| 02/21/2002 | DE10038382A1 Zweifarbiges fluorimetrisches Proteaseassay Two-toned fluorometric protease assay |
| 02/21/2002 | CA2419491A1 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 02/21/2002 | CA2419338A1 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
| 02/21/2002 | CA2419203A1 Phage-dependent superproduction of biologically active protein and peptides |
| 02/21/2002 | CA2419157A1 Improved insecticidal bacteria, and methods for making and using them |
| 02/21/2002 | CA2418725A1 Claudin polypeptides |
| 02/21/2002 | CA2418303A1 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 02/21/2002 | CA2417141A1 Novel glycoproteins and methods of use thereof |
| 02/20/2002 | EP1180525A1 Transcriptional activation inhibitory protein |
| 02/20/2002 | EP1180153A1 Phage-dependent super-production of biologically active proteins and peptides |
| 02/20/2002 | EP1180148A1 A VARIANT OF C6 BETA-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY |
| 02/20/2002 | EP1180147A1 Secreted alpha-helical protein-31 |
| 02/20/2002 | EP1180146A1 Secreted alpha-helical protein - 32 |
| 02/20/2002 | EP1180145A1 Biosynthesis of foreign proteins using transformed microalgae |
| 02/20/2002 | EP1180144A2 Cytoskeleton-associated proteins |
| 02/20/2002 | EP1180141A2 The p2x 3 receptor, methods of altering p2x 3receptor activity and uses thereof |
| 02/20/2002 | EP1180140A1 Variants of traf2 which act as an inhibitor of tnf-alpha signaling pathway |
| 02/20/2002 | EP1180120A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
| 02/20/2002 | EP1180119A2 RECOMBINANT $i(HAEMOPHILUS INFLUENZAE) ADHESIN PROTEINS |
| 02/20/2002 | EP0749485B1 Antimicrobial proteins from impatiens |
| 02/20/2002 | EP0728215B1 METHOD OF BINDING MATERIAL TO THE Beta-AMYLOID PEPTIDE |
| 02/20/2002 | EP0667904B1 Suppressor and progenitor cells |
| 02/20/2002 | CN1336957A BASB006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 02/20/2002 | CN1336436A Method of improving soluble expression of foreign gene in colon bacillus |
| 02/20/2002 | CN1336381A Trichosanthin mutant and its prepn. |
| 02/19/2002 | US6348582 Prokaryotic polynucleotides polypeptides and their uses |
| 02/19/2002 | US6348580 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate |
| 02/19/2002 | US6348579 FtsL |
| 02/19/2002 | US6348578 Apt |
| 02/19/2002 | US6348574 An antibody; diagnosis and therapy for tumors, strokes, vasoconstriction, bronchial asthma, and atherosclerosis |
| 02/19/2002 | US6348351 Tie receptor tyrosine kinase ligand homologues |
| 02/19/2002 | US6348335 Metabolism active materials, heating and cooling yeasts then isolation |
| 02/19/2002 | US6348334 DNA encoding Fas ligand |
| 02/19/2002 | US6348332 DNA molecule encoding gonorrhoeal hybrid PIA/PIB protein |
| 02/19/2002 | US6348329 Isolation of polynucleotide sequence codes of polypeptide with amino acid sequences |
| 02/19/2002 | US6348327 Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells |
| 02/19/2002 | CA2141060C Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods |
| 02/19/2002 | CA2023246C Mutants of human interleukin-3 |
| 02/14/2002 | WO2002012902A2 Split-ubiquitin based reporter systems and methods of their use |
| 02/14/2002 | WO2002012899A2 Peptides presented by cells |
| 02/14/2002 | WO2002012537A2 Mutant trichosanthin |
| 02/14/2002 | WO2002012535A1 Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotherapy |
| 02/14/2002 | WO2002012508A2 Method for improved production of cyanophycin and the secondary products thereof |
| 02/14/2002 | WO2002012502A2 Anti-tnf antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012501A2 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012500A2 Anti-il-12 antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012485A1 Promoter, vector and recombinant microorganism having the same and process for producing protein |
| 02/14/2002 | WO2002012467A2 Drug metabolizing enzymes |
| 02/14/2002 | WO2002012459A2 Method for improved production of cyanophycin and the secondary products thereof |
| 02/14/2002 | WO2002012345A2 Soluble zcytor 11 cytokine receptors |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012339A2 Sequences for integrin alpha-8 |
| 02/14/2002 | WO2002012326A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 02/14/2002 | WO2002012307A1 Urocortin proteins and uses thereof |
| 02/14/2002 | WO2002012290A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
| 02/14/2002 | WO2002012286A2 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | WO2002012284A2 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease |